BioSante Pharmaceuticals, Inc. (BPAX)

[Winalov]

Maybe some of us, are pointing in right direction???
The story of Fanapt "dead" after the FDA rejected the drug in July 2008. The "not approvable" letter issued by the FDA at that time raised
concerns about the efficacy of Fanapt and asked Vanda to conduct a new clinical trial and collect additional safety data.
Vanda didn't run a new clinical trial for Fanapt, choosing instead to resubmit the drug to the FDA
with additional data from its existing clinical trials.
http://www.thestreet.com/story/10497618/1/surprising-approval-for-vandas-fanapt.html

I know this is big stretch of hope but.......until the management opens their mouth again with reality check......it sounds very good.